- CEO
- Ajaykumar Natvarlal Sangani
- Full Time Employees
- 162
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Sainath Society, Opp. S.T., KSD T, Village Keshod, Taluka Keshod Junagadh GU India 362220
- IPO Date
- Aug 17, 2023
- Business
- Sangani Hospitals Limited (NSE: SANGANI) operates multi-specialty hospitals, pathology laboratories, and pharmacy stores primarily in the Keshod and Veraval regions of Gujarat, India. The company offers a comprehensive range of primary, secondary, and tertiary healthcare services, including specialty and super specialty care in cardiac sciences, neurosciences, orthopedics, renal sciences, mother and childcare; general medicine, urology surgery, laparoscopic surgery, ENT head and neck surgery, gynecology, infertility clinic, dialysis, endoscopy, audiology, vertigo clinic, radiology (X-ray, sonography, CT scan), and other support services such as MD-ICU, ICCU, echo, TMT, and EECP. It operates two key facilities: Sangani Hospital, a 36-bed multi-specialty hospital in Keshod, Junagadh district, offering primary to tertiary care and preparing for NABH accreditation; and Sangani Super Speciality Hospital, a 32-bed NABH entry-level certified facility in Veraval, Gir Somnath district, with a focus on tertiary care. Additional operations include two pathology laboratories and two medical stores, with free dialysis services provided to thousands of patients annually under government schemes like PM-JAY and Mukhyamantri Amrutum Yojana.
Incorporated on November 11, 2021, in Ahmedabad, Gujarat, under the Companies Act, 2013, the company is promoted by Dr. Ajaykumar Natwarlal Sangani and Dr. Rajeshkumar Natwarlal Sangani, with headquarters effectively based in Keshod, Gujarat (Sainath Society, Opp. S.T., KSD Taluka). The hospitals comply with ISO 9001:2015 quality management standards across various departments and participate in government schemes for free surgeries. Sangani Hospitals targets underserved rural and semi-urban populations in Gujarat, serving patients from over 50 adjacent villages through strategically located facilities near transport hubs.
In recent developments, the company listed its equity shares on the National Stock Exchange of India on August 17, 2023, enabling public funding for expansions. It launched an ultra-modern dialysis center in Keshod in 2023 and received the News 18 Gujarati award for Most Trusted and Exemplary Hospital in Keshod. On March 7, 2024, Sangani Hospitals entered a Memorandum of Understanding to acquire Aashirvad Hospital, followed by a share purchase agreement on March 28, 2025, to acquire a 55% stake (12,223 equity shares) in Sadbhavna Hospital and Medical Research Centre Pvt. Ltd. for ₹18.81 crore in cash, aiming for strategic expansion and alignment in healthcare services, with completion expected within one year. Earlier, in December 2021, it acquired running businesses from related proprietorships and partnerships, including Sangani Laboratories, Ankur Laboratory, Ankur Medical Store, Ankur Medicines, and Sangani Super Speciality Hospital via business transfer agreements, and took 95% ownership in Ankur Distributors. These moves support bed capacity growth, new service diversification, and infrastructure upgrades at its Gujarat facilities.